Chugai Pharmaceutical Co., Ltd.
4519
Rang in aandelen
#356
Chugai Pharmaceutical Co., Ltd. is a prominent global pharmaceutical company,... Chugai Pharmaceutical Co., Ltd. is a prominent global pharmaceutical company, operating subsidiaries involved in the full lifecycle of drug development, from research and manufacturing to sales, import, and export, serving both Japanese and international markets. Its commercialized product portfolio spans several key therapeutic areas. These include a robust oncology offering with leading treatments like Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda. Additionally, it provides medications for bone health (e.g., Actemra, Edirol, Bonviva), renal conditions (such as Mircera and Oxarol), and neurological or other diverse ailments (including Hemlibra, CellCept, and Enspryng). Beyond its existing offerings, the company maintains an active research and development pipeline. This pipeline features multiple promising candidates targeting oncology, orthopedic and joint disorders, autoimmune diseases, kidney-related conditions, and various neurological or other health issues. Strategic partnerships are central to Chugai's operations, most notably a significant alliance with the Roche Group. The company also fosters collaborative research initiatives with academic institutions. Established in 1925, Chugai's headquarters are located in Tokyo, Japan, and it operates as a key subsidiary of Roche Holding Ltd.
Aandeelprijs
$41.71
Laatst gesynchroniseerd: 2026-10-16
Marktkapitalisatie
$68.64B
Verandering (1 dag)
2.01%
Verandering (1 jaar)
-14.16%
Land
JP
Handel Chugai Pharmaceutical Co., Ltd. (4519)
Categorie
Healthcare
Marktkapitalisatie van Chugai Pharmaceutical Co., Ltd.(4519)
Marktkapitalisatie: $68.64B
Vanaf October 2026 heeft Chugai Pharmaceutical Co., Ltd. een marktkapitalisatie van $68.64B. Dit maakt Chugai Pharmaceutical Co., Ltd. volgens onze gegevens het 356th meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van Chugai Pharmaceutical Co., Ltd. van 2000 tot 2026
4519 vergeleken met de top 5 populairste stocks
